MedTrace Logo

Massive Open Online Course (MOOC) for Women with Breast Cancer

NCT06635239 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-10-10

No results posted yet for this study

Summary

The goal of this clinical trial is to promote Person-Centered Care and improve Health Literacy and Digital Health Literacy in women with breast cancer through the development of a Massive Open Online Course (MOOC) co-created with women with breast cancer.

Conditions

Interventions

OTHER

Co-creation and assessment

1. MOOC co-creation: development of a MOOC initially structured into modules consisting of a variety of downloadable educational resources such as videos, audios, infographics, texts, etc., covering several units related to Person-Centered Care (Shared Decision-Making, strategies for managing the clinical encounter, Patient Decision Aids, etc.) and Digital Health Literacy (skills, tools, etc.). These resources will serve as the central focus of the educational intervention, and may undergo appropriate adjustments established during the co-creation sessions. 2. MOOC acceptability and effectiveness: evaluation of the MOOC in terms of effectiveness (level of Health Literacy, Digital Health Literacy, and knowledge acquired) and acceptability (usability, areas for improvement, etc.)

Sponsors & Collaborators

  • Servicio de Evaluación del Servicio Canario de Salud

    collaborator UNKNOWN

  • Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias

    collaborator OTHER

  • University of La Laguna

    collaborator OTHER

  • University of Barcelona

    collaborator OTHER

  • FEFOC fundation

    collaborator UNKNOWN

  • Parc Taulí Hospital Universitari

    collaborator OTHER

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Yolanda Alvarez-Perez

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-17
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06635239 on ClinicalTrials.gov